GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 211 filers reported holding GENMAB A/S in Q1 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $24,401 | -16.0% | 971 | 0.0% | 0.01% | -22.2% |
| Q1 2024 | $29,043 | +8.6% | 971 | +15.6% | 0.01% | 0.0% |
| Q4 2023 | $26,746 | +275.4% | 840 | +315.8% | 0.01% | +200.0% |
| Q3 2023 | $7,125 | -7.2% | 202 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $7,678 | +0.7% | 202 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $7,628 | +84655.6% | 202 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $9 | -99.8% | 202 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | -25.0% | 202 | -12.6% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | 0.0% | 231 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $8,000 | -11.1% | 231 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $9,000 | -10.0% | 231 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $10,000 | +66.7% | 231 | +56.1% | 0.00% | 0.0% |
| Q4 2020 | $6,000 | +20.0% | 148 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $5,000 | – | 148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 214,848 | $6,980,000 | 2.38% |
| Cutter & CO Brokerage, Inc. | 119,956 | $3,897,000 | 1.33% |
| Hardman Johnston Global Advisors LLC | 933,449 | $30,328,000 | 1.29% |
| Connective Portfolio Management, LLC | 18,000 | $585,000 | 1.00% |
| Capricorn Fund Managers Ltd | 148,411 | $4,822,000 | 0.88% |
| TORRAY INVESTMENT PARTNERS LLC | 131,708 | $4,279,000 | 0.82% |
| First Light Asset Management, LLC | 160,885 | $5,227,000 | 0.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,857 | $57,189,000 | 0.60% |
| Yorktown Management & Research Co Inc | 10,100 | $328,000 | 0.42% |
| Integrated Investment Consultants, LLC | 18,550 | $602,000 | 0.22% |